Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05720468 · ClinicalTrials.gov registry record · NA

Exercise for Cognitive Excellence in Parkinson's Disease

A NA study of Parkinson Disease, sponsored by University of California, San Francisco.

Recruiting
Registry status
NA
Development phase
32
Enrollment target
1
Study location

NCT05720468 is a NA study of Parkinson Disease that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 32 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05720468, a NA study of Parkinson Disease, is actively recruiting participants, sponsored by University of California, San Francisco.

RECRUITING
Registry status
NA
Development phase
32 participants
Enrollment target
1
Study location

Study Summary

This study will evaluate the safety and feasibility of a home-based, virtually-supervised, combined high intensity endurance and resistance training program in people with Parkinson's disease. It will also evaluate the effects of exercise on cognition and underlying exercise-related biological markers (biomarkers).

Conditions Studied

Interventions

  • OTHER Exercise
  • OTHER No Exercise

Study Locations (1)

California

  • University of California San Francisco - San Francisco

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2023-07-20
Est. Completion 2026-12-01
Phase NA

What the Registry Record Tells You About NCT05720468

The ClinicalTrials.gov registry entry for NCT05720468 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Parkinson Disease appearing as the primary indexed condition, and to 2 interventions - of which Exercise is the first listed.

NCT05720468 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05720468 about?

NCT05720468 is a clinical study titled "Exercise for Cognitive Excellence in Parkinson's Disease". This study will evaluate the safety and feasibility of a home-based, virtually-supervised, combined high intensity endurance and resistance training program in people with Parkinson's disease. It will also evaluate the effects of exercise on cognition and underlying exercise-related biological marke...

What is the current status of trial NCT05720468?

This trial is currently recruiting. It is a NA study. The enrollment target is 32 participants. The study started on 2023-07-20. Estimated completion is 2026-12-01.

What conditions does trial NCT05720468 study?

This clinical trial studies the following conditions: Parkinson Disease.

What interventions are being tested in trial NCT05720468?

The interventions under investigation include: Exercise (OTHER), No Exercise (OTHER).

Who is sponsoring clinical trial NCT05720468?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05720468 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Parkinson Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.